Log-in / Create Account  
Session Information
2007 BIO International Convention
Click here to go to the previous page
Stem Cells: Importance to Research and to Treatments
Track : Regenerative Medicine
Program Code: RGM020
Date: Tuesday, May 8, 2007
Time: 11:00 AM to 12:30 PM  
Location: 252 AB
CHAIR :
Stephen Livesey, MD, PhD, CEO, Australian Stem Cell Centre
SPEAKER (S):
Robert Klein, Chairman, Independent Citizens' Oversight Committee, California Institute for the Regenerative Medicine
 Mahendra Rao, MD, PhD, Vice President, Research, Invitrogen Corporation, CA, United States
Nadia Rosenthal, PhD, Head of Unit, European Molecular Biology Laboratory Monterotondo
Hans Keirstead, PhD, Associate Professor, University of California Irvine
Deborah Eppstein, PhD, President and CEO, Q Therapeutics
Description
Today, clinical trials with stem cells are poised to begin for the treatment of some neurodegenerative disorders such as spinal cord injury. At the same time, they are also being used as models for understanding the underlying cause of various diseases and creating better models for drug screening. This panel will provide an update on these developments from Australia, Europe and the United States.



Objectives:
  • Explore the current and future use of embryonic stem cells as research tools, including the creation of better cellular models for drug screening.

  • Review the most promising therapeutic areas where stem cells may have the most immediate impact.

  • Discuss next-generation applications and techniques of improving stem cell research, such as faster characterization and expanding the study of differentiation from genes to pathways.

    • Streaming Audio with
    PowerPoint Slides
    (Code: RGM020)
      
    This session is a part of:
    Regenerative Medicine 2-DAY TRACK
    Complete Set of BIO Online / CD-ROM - All 23 Tracks.